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Introduction: Scleroderma is a chronic inﬂammatory, autoimmune disease that is
characterized by generalized ﬁbrosis of skin and visceral organs. Although interstitial
pulmonary ﬁbrosis is the most common pulmonary manifestation, pulmonary
hypertension due to pulmonary vasculopathy is also seen frequently. Despite new
developments in treatment options, pulmonary hypertension accompanying connec-
tive tissue disease such as scleroderma has a poor prognosis. The objective of this
study was to determine mortality in scleroderma patients with pulmonary hypertension
as well as the predictors of mortality.
Materials-Methods: 21 scleroderma patients with pulmonary hypertension were
included in this study. The patients had a detail history, physical examination and
electrocardiography performed and pulmonary hypertension was diagnosed by
transthoracic echocardiography along with right heart catheterization during which
systolic, diastolic and mean pulmonary artery pressures were measured. High reso-
lution tomography was used to diagnose interstitial pulmonary disease and inﬂam-
matory markers and autoantibodies were also measured. 6 minute walking test was
used to evaluate functional capacity during diagnosis and evaluation of pulmonary
capacity was performed by pulmonary function testing and diffusion capacity
measurements. All patients were followed with hospital visits and mortality was
determined from hospital records.
Results: Patients included in the study were predominantly females (16 females, 5
males); the mean age was 57.9 years (38 - 82) and mean follow-up period was
9.66.8 years. 7 (33%) patients died during follow-up. The demographic and imaging
test characteristics are shown in Table 1 and the results of catheterization and 6 minute
walking test are shown in Table 2. In single variable analysis, distant organ
involvement and presence of digital ulcer, low body mass index, degree of tricuspid
regurgitation and systolic pulmonary pressure in echocardiography, and CRP level
were found to be signiﬁcant as predictors of mortality. In multiple variable analysis,
presence of digital ulcer and CRP level were found to be signiﬁcant as predictors
of mortality in scleroderma patients with pulmonary hypertension.
Discussion: Pulmonary hypertension accompanying scleroderma seriously decreases
the survival of these patients. Determination of high risk patients is important for
intensiﬁcation of treatment strategies and early intervention. In this study, approxi-
mately one-thirds of the patients died in about 10 years of follow-up. This study sheds
light on the possible predictors of mortality of these patients and these predictors can
be used for the early determination of high risk patients.Table 1
Age (years) 57,9  12,0
Sex (female) 16
Body mass index (kg/m2) 27,1  4,3
End diastolic diameter (cm) 4,4  0,3
End systolic diameter (cm) 2,8  0,4
Ejection fraction (%) 65,5  7,2
Diastolic right ventricular diameter (cm) 2,9  0,5
Pulmonary arterial pressure (mmHg) 65,0  34,0
Diffusion capacity (%) 45,6  13,0
Pulmonary artery diameter on CT 34,8  3,2
Baseline demographic and imaging characteristics
Table 2
6 min walking distance (meter) 262,4  96,1
Before 6 min walking dyspnea score (1-10) 3,4  2,5
After 6 min walking dyspnea score (1-10) 4,6  2,2
Right atrial pressure (mmHg) 11,0  5,3
Right ventricular systolic pressure (mmHg) 64,7  22,6
Right ventricular diastolic pressure (mmHg) 11,8  5,9
Systolic pulmonary arterial pressure (mmHg) 65,5  23,3
Mean pulmonary arterial pressure (mmHg) 43,9  13,4
Diastolic pulmonary arterial pressure (mmHg) 28,5  9,9
Pulmonary capillary wedge pressure (mmHg) 13,2  3,6
Cardiac output (L/min) 5,6  0,7
Results of 6 minute walking test and right heart catheterization
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Introduction: Recent studies have demonstrated the potential role of microRNAs
(miRNA) as biomarkers in various cardiovascular disorders. Left ventricle hyper-
trophy and dilatation are among changes encountered in the remodeling process in
patients with congestive heart failure (CHF).
The aim of this study was to investigate the relationship between expression levels
of dysregulated miRNAs and echocardiographic parameters related with left
ventricular mass index in chronic CHF patients.
Methods: In our study, 20 clinically stable (NYHA II) and 22 decompensated (NYHA
III and IV) systolic CHF (ejection fraction (EF) <%40) cases were enrolled. Whole
genome miRNA proﬁling was done with microarray method and dysregulated miR-
NAs were detected compared to 15 healthy controls. All patients underwent trans-
thoracic echocardiography in order to determine left ventricular EF, dimensions, left
ventricular mass index (LVMI) and tissue doppler peak systolic velocity of mitral
annulus values.
Results: A total of 29 miRNAs were up or down regulated in CHF patients. Out of
these 29 miRNAs, ﬁve were demonstrated to be correlated with LVMI values.
Speciﬁcally, miR-182 (p¼0.04), miR-200a-star (p¼0.019), and miR-568 (p¼0.023)
were found to be negatively correlated with LVMI. On the other hand, mir-155
(p¼0.019), and miR-595 (p¼0.04) were positively correlated with LVMI in patients
with CHF. There was no relation between expression levels of dysregulated miRNAs
and following echocardiographic parameters: EF (p>0.05) and tissue doppler peak
systolic velocity of mitral annulus (p>0.05).
Conclusion: This study demonstrates the signiﬁcant relationship between some, but
not all of the dysregulated miRNAs and left ventricular mass index values in systolic
CHF patients.
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Introduction: MicroRNAs (miRNAs) are small, endogenous and non-coding RNAs
that are 21-25 nucleotides in length. Recent studies have demonstrated the role of
miRNAs as potential biomarkers in various disorders. The aim of this study was to
investigate the diagnostic importance of miRNAs in congestive heart failure (CHF).
Methods: In our study, 20 clinically stable (NYHA II) and 22 decompansated (NYHA
III and IV) systolic CHF (EF<%40) patients and 15 healthy controls were enrolled.
Whole genome miRNA proﬁling was done and dysregulated miRNAs were detected
with microarray method in CHF patients compared to healthy controls. Also, the
serum levels of pro-Brain Natriuretic Peptide (BNP), high sensitive C-reactive protein
(hs-CRP) and uric acid were measured.
Results: Microarray proﬁling showed serum miR-21, miR-4278, miR-650, miR-
744star, miR-516-5p, miR-1292, miR-182, miR-1228, miR-595, miR-663b, miR-
1296, miR-1825, miR-299-3p, miR-662 miR-122-star, miR-3148, miR-518e-star,
miR-2054 as up regulated, and serum miR-129-3p, miR-3155, miR-3175, miR-583,
miR-568, miR-30d, miR-200a-star, miR-1979, miR-371-3p, miR-155-star, miR-502-
5p as down regulated in CHF.
The diagnostic values of miR-4278 (AUC 1.00 p<0.0001), miR-516-a-5p (AUC
1.00 p<0.0001) and miR-1228 (AUC 1.00 p<0.0001) were found to be very high
compared to other known important clinical prognostic markers as pro-BNP (AUCLS C17
